Microbot Medical Inc (MBOT) has released an update to notify the public and investors about a regulation fd disclosure.
On January 30, 2024, the Company announced via a press release that it had entered into a Settlement Agreement. This information, provided in the Current Report on Form 8-K and its Exhibit 99.1, is for informational purposes and not considered “filed” under Section 18 of the Securities Exchange Act of 1934, nor is it subject to the associated liabilities, nor does it constitute an admission of materiality.
For further insights into MBOT stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.
